ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,233,422 | -17.5% | 157,552 | +9.5% | 0.82% | -3.7% |
| Q2 2023 | $5,132,259 | +32.6% | 143,922 | +50.9% | 0.86% | +14.3% |
| Q4 2022 | $3,869,424 | +18.5% | 95,400 | -3.4% | 0.75% | +16.5% |
| Q3 2022 | $3,265,000 | -20.6% | 98,800 | -15.4% | 0.64% | -22.4% |
| Q2 2022 | $4,113,000 | -25.3% | 116,800 | -2.4% | 0.83% | -15.1% |
| Q1 2022 | $5,505,000 | -20.8% | 119,700 | +14.2% | 0.98% | -6.6% |
| Q4 2021 | $6,948,000 | +951.1% | 104,800 | +585.0% | 1.05% | +1614.8% |
| Q2 2020 | $661,000 | – | 15,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |